Contact Us

News and Events

Bora Group Partnering with Leading Universities for Campus Recruitment Events

Bora Group Partnering with Leading Universities for Campus Recruitment Events

by | Mar 1, 2023

Join the Bora Team! Bora Group, is partnering with leading universities in Taiwan to meet with students who are interested in joining the clinical development and manufacturing industry. Bora has invested heavily in growth over the last 5 years and has high demand for many positions. Bora will present at the following universities and encourages interested candidates to come out and learn what...

read more
Bora Pharmaceuticals Featured in Contract Pharma – Extrusion-Spheronization Delivery in OSD Manufacturing

Bora Pharmaceuticals Featured in Contract Pharma – Extrusion-Spheronization Delivery in OSD Manufacturing

by | Feb 22, 2023

Contract Pharma features this engaging article:  "Extrusion-Spheronization in OSD Manufacturing. How extrusion-spheronization excels delivering controlled and modified release dose forms." Published on February 21, 2023Contract Pharma In this article Bora explores delivery solutions enabled by the E-S manufacturing process and improved modified release dosage forms as well as improved patient...

read more
Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

by | Feb 7, 2023

Read Pharma Manufacturing's feature article entitled "Built to Thrive: Three CDMOs that set themselves up to flourish" Published on February 7, 2023 Thank you Pharma Manufacturing and author Karen Longhauser Pharma Manufacturing's feature article positions Bora as one of three fast growing CDMOs to watch. In their interview with Bora CEO, Bobby Sheng, the author acknowledges Bora's values...

read more

Bora Pharmaceuticals Featured in Pharma Intelligence Generic Bulletin

by | Jan 23, 2023

Bora Pharmaceuticals is mentioned as "the largest pharmaceutical group by volume in Taiwan" in 2022 after completing the company's "landmark acquisition" of TWi Pharmaceuticals. Published in the online version of Generics Bulletin. https://generics.pharmaintelligence.informa.com/GB152440/Standalone-Sandoz-And-Biocons-Biosimilars-2022s-Biggest-Deals Thank you Pharma Intelligence andAuthor Dean...

read more

Get the industry insights you care about

Join 3000+ subscribers and receive BORA resources in your inbox.

Resources by Category